BDBM236795 US9388149, 2 (Diastereoisomer 1)::US9388149, 2 (Diastereoisomer 2)::US9388149, 2 (Enantiomer 1 of diastereoisomer 1)::US9388149, 2 (Enantiomer 1 of diastereoisomer 2)::US9388149, 2 (Enantiomer 2 of diastereoisomer 1)::US9388149, 2 (Enantiomer 2 of diastereoisomer 2)::US9580412, Example 2

SMILES CN(C)C(=O)c1cccc(Nc2c(NC(C3CCCS3)c3ccc(C)o3)c(=O)c2=O)c1O

InChI Key InChIKey=KCVWGCOBGFLUEB-UHFFFAOYSA-N

Data  12 IC50

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 236795   

TargetC-X-C chemokine receptor type 2(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 15nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 2(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 35nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 1(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 44nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDB
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 2(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 56nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 1(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 77nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDB
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 2(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 134nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 2(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 135nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 2(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 273nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 1(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 661nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDB
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 1(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 692nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDB
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 1(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 1.56E+3nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDB
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetC-X-C chemokine receptor type 1(Human)
Galderma Research & Development

US Patent

LigandBDBM236795(US9388149, 2 (Enantiomer 1 of diastereoisomer 2) |...)Copy SMILESCopy InChI

Affinity DataIC50: 4.55E+3nMT: 2°CAssay Description: PathHunter HEK293-CXCR2 or U2OS hCXCR1 β-arrestin cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in...More data for this Ligand-Target Pair

Target InfoPDB
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/10/2017
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL